BriaCell Therapeutics Corp Live Stock Price Today, Share Analysis and Chart

Name: BriaCell Therapeutics Corp: Is Infosys Ltd. worth buying?
Item: BriaCell Therapeutics Corp
Rating: 1.18000
Author: Trendlyne DVM scores

about

BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combin...

0.75 -0.05 (-6.25%)

92.36% Fall from 52W High

1.7M

XNAS Volume

XNAS 31 Jul, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

15.0 / 100

Technically Bearish

32.2 / 100

No estimates available

BriaCell Therapeutics Corp Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

BriaCell Therapeutics Corp Live Stock Price Today, Share Analysis and Chart

BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combin...

92.36% Fall from 52W High

SWOT Analysis

BriaCell Therapeutics Corp Live Price Chart